Michael Byrnes - 15 May 2023 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Michael Byrnes
Issuer symbol
EFTR on OTC
Transactions as of
15 May 2023
Net transactions value
+$2,232
Form type
4
Filing time
16 May 2023, 08:01:44 UTC
Previous filing
19 Jan 2023
Next filing
16 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Award $2,232 +4,863 +14% $0.4590 38,747 15 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.